These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 30456712)

  • 1. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Kim EA; Lim YT; Hah JO; Sohn YB; Kim YK; Choi JH; Kim SY; Jang KM; Ahn J; Lee JM
    Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Velaglucerase alfa for the management of type 1 Gaucher disease.
    Morris JL
    Clin Ther; 2012 Feb; 34(2):259-71. PubMed ID: 22264444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.
    Hosoba S; Kito K; Teramoto Y; Adachi K; Nakanishi R; Asai A; Iwasa M; Nishimura R; Moritani S; Kawahara M; Minamiguchi H; Nanba E; Kushima R; Andoh A
    Medicine (Baltimore); 2018 Jul; 97(27):e11361. PubMed ID: 29979419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
    Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
    J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase.
    Pastores GM; Petakov M; Giraldo P; Rosenbaum H; Szer J; Deegan PB; Amato DJ; Mengel E; Tan ES; Chertkoff R; Brill-Almon E; Zimran A
    Blood Cells Mol Dis; 2014 Dec; 53(4):253-60. PubMed ID: 24950666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dose of enzyme replacement therapy was successful for the pulmonary involvement in a case of type 2 Gaucher disease].
    Arai N; Uematsu M; Abe Y; Fukuyo N; Wakusawa K; Kikuchi A; Sakamoto O; Ohura T; Tsuchiya S
    No To Hattatsu; 2010 Jan; 42(1):45-9. PubMed ID: 23858612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three mutations of adult type 1 Gaucher disease found in a Chinese patient: A case report.
    Du X; Ding Q; Chen Q; Guo P; Wang Q
    Medicine (Baltimore); 2018 Nov; 97(47):e13161. PubMed ID: 30461613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
    Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
    Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy with imiglucerase in a Taiwanese child with type 1 Gaucher disease.
    Lin HY; Lin SP; Chuang CK; Wraith JE
    J Chin Med Assoc; 2006 May; 69(5):228-32. PubMed ID: 16835986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Gaucher disease type I and mild growth hormone deficiency: a new feature?
    Biasucci G; Manfredi P
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S51-4. PubMed ID: 20049531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase deficiency with coinherited Gaucher disease: A rare association.
    Parakh N; Sharma K; Sharma S; Chatterjee P; Singh V
    Indian J Pathol Microbiol; 2024 Apr; 67(2):449-451. PubMed ID: 38391334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
    van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
    J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience.
    Gumus E; Karhan AN; Hizarcioglu-Gulsen H; Demir H; Ozen H; Saltik Temizel IN; Dokmeci Emre S; Yuce A
    Eur J Med Genet; 2021 Nov; 64(11):104339. PubMed ID: 34500086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of early-treated type III Gaucher disease patients.
    Lee NC; Chien YH; Wong SL; Sheen JM; Tsai FJ; Peng SF; Leung JH; Chao MC; Shun CT; Hwu WL
    Blood Cells Mol Dis; 2014 Sep; 53(3):105-9. PubMed ID: 24984925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment.
    Weinreb NJ; Camelo JS; Charrow J; McClain MR; Mistry P; Belmatoug N;
    Mol Genet Metab; 2021 Feb; 132(2):100-111. PubMed ID: 33485799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.